Ajanta Pharma Limited — Fluconazole Exporter Profile
Indian Pharmaceutical Exporter · #13 for Fluconazole · $1.5M export value · DGFT Verified
Ajanta Pharma Limited is the #13 Indian exporter of Fluconazole with $1.5M in export value and 88 verified shipments. Ajanta Pharma Limited holds a 1.6% market share in Fluconazole exports across 12 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Fluconazole Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Fluconazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $683.2K | 18 | 61.5% |
| UGANDA | $126.7K | 15 | 11.4% |
| RWANDA | $87.4K | 9 | 7.9% |
| KYRGHYSTAN | $59.8K | 11 | 5.4% |
| ZAMBIA | $56.9K | 13 | 5.1% |
| KENYA | $37.6K | 6 | 3.4% |
| KYRGYZSTAN | $30.7K | 9 | 2.8% |
| TURKMENISTAN | $14.8K | 1 | 1.3% |
| TANZANIA | $6.3K | 1 | 0.6% |
| MALAWI | $3.5K | 1 | 0.3% |
Ajanta Pharma Limited exports Fluconazole to 13 countries. The largest destination is FRANCE accounting for 61.5% of Ajanta Pharma Limited's Fluconazole shipments, followed by UGANDA (11.4%) and RWANDA (7.9%). These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fluconazole from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PLANET PHARMA SA | FRANCE | $683.2K | 18 |
| ABACUS PHARMA (A) LTD | UGANDA | $95.8K | 10 |
| ABACUS PHARMA (A) LIMITED | RWANDA | $74.8K | 8 |
| NEMAN # PHARM LLC | KYRGHYSTAN | $42.7K | 6 |
| HARLEYS LIMITED | KENYA | $37.6K | 6 |
| ABACUS PHARMA A LIMITED | UGANDA | $26.6K | 3 |
| SONJAY LIMITED | ZAMBIA | $24.6K | 7 |
| FARMAMIR LLC | KYRGYZSTAN | $20.6K | 3 |
| SAGLYK E.S | TURKMENISTAN | $14.8K | 1 |
| KARMA PHARMACEUTICALS LIMITED, | ZAMBIA | $13.5K | 1 |
Ajanta Pharma Limited supplies Fluconazole to 25 buyers globally. The largest buyer is PLANET PHARMA SA (FRANCE), followed by ABACUS PHARMA (A) LTD (UGANDA) and ABACUS PHARMA (A) LIMITED (RWANDA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fluconazole Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $51.2M worth of Fluconazole through 8,777 shipments from 660 suppliers to 153 countries, serving 1,471 buyers globally. Ajanta Pharma Limited contributes $1.5M to this total, accounting for 1.6% of India's Fluconazole exports. Ajanta Pharma Limited ships Fluconazole to 13 countries through 25 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Fluconazole Exports?
Ajanta Pharma Limited's average Fluconazole shipment value is $16.5K per consignment, based on 88 shipments totaling $1.5M. The largest destination is FRANCE (61.5% of Ajanta Pharma Limited's Fluconazole exports).
How Does Ajanta Pharma Limited Compare to Other Indian Fluconazole Exporters?
Ajanta Pharma Limited ranks #13 among 660 Indian Fluconazole exporters with a 1.6% market share. The top 3 exporters are ZYDUS LIFESCIENCES LIMITED ($11.1M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($6.3M), AUROBINDO PHARMA LTD ($6.0M). Ajanta Pharma Limited processed 88 shipments to 12 destination countries.
What Fluconazole Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DAZEL KIT EACH KIT CONT FLUCONAZOLE TABL | $67.2K | 2 |
| DAZEL KIT[EACH KIT CONT.FLUCONAZOLE TABL | $65.1K | 7 |
| DAZEL KIT 1000/150/1000MG (EACH KIT CONT. FLUCONAZOLE TABLETS 150MG(1 TABLET)(48960KITX1=48960 TABLETS) | $50.0K | 1 |
| DAZEL KIT(38016 KITS)EACH KIT CONT.FLUCONAZOLE TABLETS 150MG(1 TABLET)(38016KITx1 TAB=38016 TABLETS) CONT.AS PER INVOICE | $50.0K | 1 |
| DAZEL KIT 1000/150/1000MG (EACH KIT CONT. FLUCONAZOLE TABLETS 150MG(1 TABLET)(75262KITx1=75262 TABLETS) | $50.0K | 1 |
| DAZEL KIT 1000/150/1000MG[EACH KIT CONT.FLUCONAZOLE TABLETS 150MG(1 TABLETS)(39206 x 1=39206 TABLETS)CONT.AS PER INVOICE | $50.0K | 1 |
| DAZEL KIT 1000/150/1000MG[108000 KITS]EACH KIT CONT:FLUCONAZOLE TABLETS 150MG(1TABLET)[108000 KITx1 TAB =108000 TABLETS] | $50.0K | 1 |
| DAZEL KIT(60048 KITS)EACH KIT CONT.FLUCONAZOLE TABLETS 150MG(1 TABLET)(60048KITx1 TAB=60048 TABLETS) CONT.AS PER INVOICE | $50.0K | 1 |
| DAZEL KIT[36000KITS]EACH KIT CONT.FLUCONAZOLE TABLETS 150MG(1 TABLET)[36000 KITx1 TAB=36000 TABLETS] CONT.AS PER INVOICE | $50.0K | 1 |
| DAZEL KIT 1000/150/1000MG EACH KIT CONT:FLUCONAZOLE TABLET 150MG(1 TAB)(37332 KITx1 TAB=37332 TABLET)CONT.AS PER INVOICE | $50.0K | 1 |
Ajanta Pharma Limited exports 66 distinct Fluconazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DAZEL KIT EACH KIT CONT FLUCONAZOLE TABL with 2 shipments worth $67.2K.
How Does Ajanta Pharma Limited Compare to Nearest Fluconazole Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | KUSUM HEALTHCARE PRIVATE LIMITED | $2.2M | 182 | 11 | $11.9K |
| 11 | GRACURE PHARMACEUTICALS LIMITED | $1.7M | 178 | 2 | $9.6K |
| 13 | AJANTA PHARMA LIMITED ★ | $1.5M | 88 | 12 | $16.5K |
| 14 | GLOBELA PHARMA PRIVATE LIMITED | $1.5M | 32 | 2 | $45.4K |
| 10 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | $1.1M | 21 | 7 | $50.0K |
Ajanta Pharma Limited ranks #13 among 660 Indian Fluconazole exporters. Average shipment value of $16.5K compared to the market average of $77.6K. The closest competitors by value are KUSUM HEALTHCARE PRIVATE LIMITED and GRACURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Fluconazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 1,099 | 12.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 988 | 11.3% |
| SAHAR AIR | 919 | 10.5% |
| DELHI AIR | 733 | 8.4% |
| NHAVA SHEVA SEA (INNSA1) | 607 | 6.9% |
| JNPT/ NHAVA SHEVA SEA | 339 | 3.9% |
| JNPT | 284 | 3.2% |
| HYDERABAD ICD | 207 | 2.4% |
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Fluconazole Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Fluconazole, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluconazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluconazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 88 individual customs records matching Ajanta Pharma Limited exporting Fluconazole, covering 66 formulations to 13 countries via 25 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 153+ countries, 1,471+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluconazole Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Fluconazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Fluconazole Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluconazole. For current shipment-level data, contact TransData Nexus.